Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Detoxifying Qingying suppository is a traditional Chinese medicine (TCM) vaginal formulation developed by Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically indicated for the treatment of persistent high-risk human papillomavirus (HPV) infection of the cervix. The suppository is designed to facilitate HPV clearance, reduce recurrence rates, and improve the vaginal microenvironment and local immune response. In clinical studies, it has been evaluated against standard treatments like recombinant human interferon alpha 2b to assess its impact on TCM syndrome scores and vaginal microecology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Detoxifying Qingying suppository.